We are live on ! Find out more
PGEN icon

Precigen

167 hedge funds and large institutions have $366M invested in Precigen in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 49 increasing their positions, 44 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

226% more call options, than puts

Call options by funds: $27.5M | Put options by funds: $8.42M

214% more capital invested

Capital invested by funds: $117M → $366M (+$250M)

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

14% more funds holding

Funds holding: 147167 (+20)

11% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 44

9.55% more ownership

Funds ownership: 27.8%37.35% (+9.5%)

Holders
167
Holders Change
+20
Holders Change %
+13.61%
% of All Funds
2.19%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
39
Increased
49
Reduced
44
Closed
18
Calls
$27.5M
Puts
$8.42M
Net Calls
+$19M
Net Calls Change
+$19.9M

PGEN Hedge Fund Activity: Q3 2025 in Review

167 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2025, worth a combined $366M — up 214% from $117M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new PGEN positions and 18 closed out — a net gain of 21 holders — while 49 added to existing stakes and 44 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $35M. The largest seller was Adage Capital Partners, cutting an estimated $29.4M.

  • 167 institutional investors held Precigen (PGEN) as of Q3 2025, up from 147 in Q2 2025.
  • Funds reported $366M of Precigen stock for Q3 2025, up 214% quarter-over-quarter.
  • 39 funds opened new Precigen positions in Q3 2025 and 18 closed out, a net change of +21 holders.
  • The largest Precigen buyer in Q3 2025 was Tang Capital Management, an estimated $35M added.
  • The largest Precigen seller in Q3 2025 was Adage Capital Partners, an estimated $29.4M sold.

Based on aggregated 13F filings for Q3 2025.